The Australian By Sarah-Jane Tasker 6 April 2018 New Breast Cancer Drug Reduces Risk of Relapse Australians with breast cancer can apply to receive a drug that reduces the risk of cancer returning, under a special access program. Nerlynx is targeted for use in women with HER 2+ early breast cancer. One in four women
![Arctica Specialised Therapeutics](https://stabiopharma.com/wp-content/uploads/2021/03/stabio-logo.png)